WHO Classification of Tumours of the Breast IARC: Lyon 2012 Estimation nationale de l'incidence et de la mortalité par cancer en France entre Disponible sur: http://www.invs.sante.fr/Publications-et-outils/Rapports-et-syntheses/Maladies- chroniques-et-traumatismes, 1980. ,
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond Engl, vol.365, issue.9472, pp.1687-717, 2005. ,
Stemming Resistance to HER-2 Targeted Therapy, Journal of Mammary Gland Biology and Neoplasia, vol.104, issue.Suppl 3, pp.55-66, 2009. ,
DOI : 10.1007/s10911-009-9116-x
pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.9, issue.5, pp.403-413, 1991. ,
DOI : 10.1016/0277-5379(88)90171-X
Highly recurrent der(1;16)(q10;p10) and other 16q arm alterations in lobular breast cancer, Genes, Chromosomes and Cancer, vol.76, issue.4, pp.300-306, 1998. ,
DOI : 10.1002/(SICI)1098-2264(199812)23:4<300::AID-GCC4>3.0.CO;2-N
Tiling Path Genomic Profiling of Grade 3 Invasive Ductal Breast Cancers, Clinical Cancer Research, vol.15, issue.8, pp.2711-2733, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1878
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?, Genes, Chromosomes and Cancer, vol.10, issue.4, pp.351-65, 2009. ,
DOI : 10.1002/gcc.20646
Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions, Genes, Chromosomes and Cancer, vol.56, issue.4, pp.372-378, 1997. ,
DOI : 10.1002/(SICI)1098-2264(199712)20:4<372::AID-GCC8>3.0.CO;2-Z
Molecular evolution of breast cancer, The Journal of Pathology, vol.189, issue.2, pp.248-54, 2005. ,
DOI : 10.1002/path.1691
Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes, Cancer Research, vol.64, issue.23, pp.8541-8550, 2004. ,
DOI : 10.1158/0008-5472.CAN-04-1992
Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-52, 2000. ,
DOI : 10.1038/35021093
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.98, issue.19, pp.10869-74, 2001. ,
DOI : 10.1073/pnas.191367098
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.452, issue.7403, pp.346-52, 2012. ,
DOI : 10.1038/nature10983
Comprehensive molecular portraits of human breast tumours, Nature, vol.16, issue.7418, pp.61-70, 2012. ,
DOI : 10.1038/nature11412
Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Annals of Oncology, vol.22, issue.8, pp.1736-1783, 2011. ,
DOI : 10.1093/annonc/mdr304
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma, Clinical Cancer Research, vol.10, issue.16, pp.5367-74, 2004. ,
DOI : 10.1158/1078-0432.CCR-04-0220
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors, Modern Pathology, vol.3, issue.10, pp.1321-1329, 2005. ,
DOI : 10.1038/modpathol.3800456
Translocation-Related Sarcomas, Seminars in Oncology, vol.36, issue.4, pp.312-335, 2009. ,
DOI : 10.1053/j.seminoncol.2009.06.004
WHO Classification of Tumours of Soft Tissue and Bone, 2013. ,
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 2008. ,
Translocations in epithelial cancers, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1796, issue.2, pp.201-216, 2009. ,
DOI : 10.1016/j.bbcan.2009.04.005
Morphologic Features of Carcinomas With Recurrent Gene Fusions, Advances In Anatomic Pathology, vol.19, issue.6, pp.417-441, 2012. ,
DOI : 10.1097/PAP.0b013e318273baae
WHO Classification of Tumors of Endocrine Organs, 2004. ,
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer, Science, vol.310, issue.5748, pp.644-652, 2005. ,
DOI : 10.1126/science.1117679
Recurrent gene fusions in prostate cancer, Nature Reviews Cancer, vol.10, issue.7, pp.497-511, 2008. ,
DOI : 10.1038/nrc2402
WHO Classification of Tumours of the Urinary System and Male Genital Organs, 2004. ,
Activated RET and ROS: two new driver mutations in lung adenocarcinoma, Transl Lung Cancer Res, vol.2, issue.2, pp.112-133, 2013. ,
Breast Carcinoma in Children, JAMA: The Journal of the American Medical Association, vol.195, issue.5, pp.388-90, 1966. ,
DOI : 10.1001/jama.1966.03100050096033
Secretory carcinoma of the breast, Cancer, vol.375, issue.9, pp.2404-2417, 1980. ,
DOI : 10.1002/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8
Secretory carcinoma of the breast, Arch Pathol Lab Med, vol.115, issue.2, pp.141-145, 1991. ,
Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis, Histopathology, vol.9, issue.1, pp.25-36, 1989. ,
DOI : 10.1002/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8
Secretory carcinoma of the breast in adults, The American Journal of Surgical Pathology, vol.4, issue.5, pp.465-70, 1980. ,
DOI : 10.1097/00000478-198010000-00006
Secretory carcinoma of the breast in adults. Light and electron microscopic study of three cases with review of the literature, Cancer, vol.99, issue.12, pp.2245-54, 1983. ,
DOI : 10.1002/1097-0142(19830615)51:12<2245::AID-CNCR2820511216>3.0.CO;2-I
Secretory carcinoma of the breast: Results from the survival, epidemiology and end results database, The Breast, vol.21, issue.3, pp.350-353, 2012. ,
DOI : 10.1016/j.breast.2012.02.013
Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature, Modern Pathology, vol.87, issue.4, pp.567-75, 2012. ,
DOI : 10.1007/s00404-010-1669-9
Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry, Human Pathology, vol.34, issue.12, pp.1299-305, 2003. ,
DOI : 10.1016/S0046-8177(03)00423-4
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum, Mod Pathol Off J U S Can Acad Pathol Inc, vol.22, issue.2, pp.291-299, 2009. ,
Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis, Histopathology, vol.7, issue.4, pp.509-528, 2013. ,
DOI : 10.1111/his.12172
Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6???split apart??? probes, Histopathology, vol.7, issue.7, pp.840-846, 2008. ,
DOI : 10.1002/gcc.20200
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma, Cancer Cell, vol.2, issue.5, pp.367-76, 2002. ,
DOI : 10.1016/S1535-6108(02)00180-0
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma, Nature Genetics, vol.2, issue.2, pp.184-191, 1998. ,
DOI : 10.1006/abio.1987.9999
Cytogenetic and Molecular Characterization of a Congenital Mesoblastic Nephroma, Pediatric and Developmental Pathology, vol.4, issue.4, pp.402-413, 2001. ,
DOI : 10.1007/s10024001-0034-1
Cellular Mesoblastic Nephroma: Morphologic, Cytogenetic and Molecular Links with Congenital Fibrosarcoma, Pathology - Research and Practice, vol.199, issue.1, pp.35-40, 2003. ,
DOI : 10.1078/0344-0338-00350
ETV6-NTRK3 Gene Fusions and Trisomy 11 Establish a Histogenetic Link between Mesoblastic Nephroma and Congenital Fibrosarcoma, Cancer Res, vol.58, issue.22, pp.5046-5054, 1998. ,
Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25), Blood, vol.93, issue.4, pp.1355-63, 1999. ,
A unique translocation of the TEL gene in a case of acute myelogenous leukemia with inv(12)(p13q15), Blood, vol.92, issue.4, pp.1454-1459, 1998. ,
Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia, Diagnostic Pathology, vol.6, issue.1, p.19, 2011. ,
DOI : 10.1128/MCB.24.11.4636-4650.2004
Mammary Analogue Secretory Carcinoma of Salivary Glands, Containing the ETV6-NTRK3 Fusion Gene: A Hitherto Undescribed Salivary Gland Tumor Entity, Am J Surg Pathol, vol.34, issue.5, pp.599-608, 2010. ,
Most Nonparotid ???Acinic Cell Carcinomas??? Represent Mammary Analog Secretory Carcinomas, The American Journal of Surgical Pathology, vol.37, issue.7, pp.1053-1060, 2013. ,
DOI : 10.1097/PAS.0b013e3182841554
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686973
Unmasking MASC: Bringing to Light the Unique Morphologic, Immunohistochemical and Genetic Features of the Newly Recognized Mammary Analogue Secretory Carcinoma of Salivary Glands, Head and Neck Pathology, vol.105, issue.1, pp.35-44, 2013. ,
DOI : 10.1007/s12105-013-0429-0
GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms, Head and Neck Pathology, vol.20, issue.4, pp.311-316, 2013. ,
DOI : 10.1007/s12105-013-0442-3
Secretory Carcinoma in the Axilla, The American Journal of Surgical Pathology, vol.33, issue.6, pp.950-953, 2009. ,
DOI : 10.1097/PAS.0b013e31819c2628
Mammary-type Secretory Carcinoma of the Skin, The American Journal of Surgical Pathology, vol.34, issue.8, pp.1226-1233, 2010. ,
DOI : 10.1097/PAS.0b013e3181e4f49d
ETV6-NTRK3???Trk-ing the primary event in human secretory breast cancer, Cancer Cell, vol.2, issue.5, pp.347-355, 2002. ,
DOI : 10.1016/S1535-6108(02)00184-8
A fluorescence in situ hybridization study ofETV6-NTRK3 fusion gene in secretory breast carcinoma, Genes, Chromosomes and Cancer, vol.25, issue.2, pp.152-159, 2004. ,
DOI : 10.1002/gcc.20028
ETV6 gene rearrangements in invasive breast carcinoma, Genes, Chromosomes and Cancer, vol.23, issue.1, pp.103-111, 2005. ,
DOI : 10.1002/gcc.20200
ETV6 fusion genes in hematological malignancies: A review, Leukemia Research, vol.36, issue.8, pp.945-61, 2012. ,
DOI : 10.1016/j.leukres.2012.04.010
The TEL/ETV6 gene is required specifically for hematopoiesis in the bone??marrow, Genes & Development, vol.12, issue.15, pp.2392-402, 1998. ,
DOI : 10.1101/gad.12.15.2392
The ETS-related factor TEL is regulated by angiogenic growth factor VEGF in HUVE-cells, Anticancer Res, vol.18, issue.6A, pp.4505-4514, 1998. ,
Fusion of PDGF receptor ?? to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation, Cell, vol.77, issue.2, pp.307-323, 1994. ,
DOI : 10.1016/0092-8674(94)90322-0
The Trk family of neurotrophin receptors, Journal of Neurobiology, vol.159, issue.11, pp.1386-403, 1994. ,
DOI : 10.1002/neu.480251107
ETV6???NTRK3: a chimeric protein tyrosine kinase with transformation activity in multiple cell lineages, Seminars in Cancer Biology, vol.15, issue.3, pp.215-238, 2005. ,
DOI : 10.1016/j.semcancer.2005.01.003
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation, Oncogene, vol.48, issue.10, pp.1334-1374, 2012. ,
DOI : 10.1038/onc.2011.323
ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway, Cancer Research, vol.71, issue.3, pp.1060-70, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3096
The detection of Tel-TrkC chimeric transcripts is more specific than TrkC immunoreactivity for the diagnosis of congenital fibrosarcoma, The Journal of Pathology, vol.278, issue.1, pp.88-94, 2001. ,
DOI : 10.1002/1096-9896(2000)9999:9999<::AID-PATH724>3.0.CO;2-S
ETV6???NTRK3 as a therapeutic target of small molecule inhibitor PKC412, Biochemical and Biophysical Research Communications, vol.429, issue.1-2, pp.87-92, 2012. ,
DOI : 10.1016/j.bbrc.2012.10.087
Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication, Journal of Clinical Pathology, vol.62, issue.7, pp.604-616, 2009. ,
DOI : 10.1136/jcp.2008.059675
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer, Journal of Clinical Oncology, vol.28, issue.16, pp.2784-95, 2010. ,
DOI : 10.1200/JCO.2009.25.6529
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.31, pp.3997-4013, 2013. ,
DOI : 10.1200/JCO.2013.50.9984
Mitotic Checkpoints and Chromosome Instability Are Strong Predictors of Clinical Outcome in Gastrointestinal Stromal Tumors, Clinical Cancer Research, vol.18, issue.3, pp.826-864, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-1610
A Case of Estrogen Receptor Positive Secretory Carcinoma in a 9-Year-old Girl With ETV6-NTRK3 Fusion Gene, Japanese Journal of Clinical Oncology, vol.42, issue.3, pp.208-219, 2012. ,
DOI : 10.1093/jjco/hyr187
ETV6 Disruption Does Not Predict Indolent Clinical Behavior in Secretory Breast Carcinoma, The Breast Journal, vol.18, issue.6, pp.604-610, 2012. ,
DOI : 10.1111/tbj.12041
Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature, World Journal of Surgical Oncology, vol.3, issue.1, p.35, 2005. ,
DOI : 10.1186/1477-7819-3-35
A rare case of secretory breast carcinoma in a male adult with axillary lymph node metastasis, Int J Clin Exp Pathol, vol.8, issue.3, pp.3322-3329, 2015. ,
Secretory carcinoma of breast: clinicopathologic study of 8 cases, Annals of Diagnostic Pathology, vol.17, issue.1, pp.54-61, 2013. ,
DOI : 10.1016/j.anndiagpath.2012.06.001
Case report: Secretory breast cancer in an 11-year-old girl, Journal of Pediatric Surgery Case Reports, vol.1, issue.10, pp.357-365, 2013. ,
DOI : 10.1016/j.epsc.2013.09.008
Secretory Carcinoma of Male Breast: Case Report and Review of the Literature, International Journal of Breast Cancer, vol.9, issue.4, pp.1-5, 2011. ,
DOI : 10.1002/gcc.20028
ETV6???NTRK3 gene fusion in a secretory carcinoma of the breast of a male-to-female transsexual, The Breast, vol.14, issue.1, pp.71-75, 2005. ,
DOI : 10.1016/j.breast.2004.04.005
S100 protein positive human breast carcinomas: An immunohistochemical study, Journal of Surgical Oncology, vol.34, issue.2, pp.108-121, 1994. ,
DOI : 10.1002/jso.2930550210
Fungating Breast Mass, Disponible sur, 2009. ,
Secretory breast carcinoma???case report and review of the medical literature, The Breast, vol.13, issue.4, pp.353-358, 2004. ,
DOI : 10.1016/j.breast.2004.01.005
Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: Case report and review of the literature, Annals of Oncology, vol.11, issue.10, pp.1343-1350, 2000. ,
DOI : 10.1023/A:1008387800525
Secretory carcinoma of breast in a 17-year-old male, World Journal of Surgical Oncology, vol.2, issue.1, p.17, 2004. ,
DOI : 10.1186/1477-7819-2-17
Secretory breast carcinoma with metastatic sentinel lymph node, World Journal of Surgical Oncology, vol.4, issue.1, p.88, 2006. ,
DOI : 10.1186/1477-7819-4-88
Mammary Analogue Secretory Carcinoma of Salivary Glands With High-grade Transformation, The American Journal of Surgical Pathology, vol.38, issue.1, pp.23-33, 2014. ,
DOI : 10.1097/PAS.0000000000000088
Das sekretorische Mammakarzinom, Geburtshilfe und Frauenheilkunde, vol.49, issue.03, pp.299-301, 1989. ,
DOI : 10.1055/s-2008-1035759
Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma, Oral Oncology, vol.33, issue.4, pp.275-283, 1997. ,
DOI : 10.1016/S0964-1955(97)00026-2
Carcinome s??cr??toire du sein chez l???homme, Annales de Pathologie, vol.24, issue.5, pp.432-437, 2004. ,
DOI : 10.1016/S0242-6498(04)93999-5
Breast carcinoma in children, JAMA, vol.195, pp.144-146, 1966. ,
Secretory carcinoma. WHO Classification of Tumors of the Breast, Lyon: IARC, vol.2012, pp.71-72 ,
Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature, Modern Pathology, vol.87, issue.4, pp.567-575, 2012. ,
DOI : 10.1007/s00404-010-1669-9
Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basallike carcinoma spectrum, Mod Pathol, vol.22, pp.291-298, 2009. ,
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma, Cancer Cell, vol.2, issue.5, pp.367-376, 2002. ,
DOI : 10.1016/S1535-6108(02)00180-0
A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma, Nature Genetics, vol.2, issue.2, pp.184-187, 1998. ,
DOI : 10.1006/abio.1987.9999
Cytogenetic and Molecular Characterization of a Congenital Mesoblastic Nephroma, Pediatric and Developmental Pathology, vol.4, issue.4, pp.402-411, 2001. ,
DOI : 10.1007/s10024001-0034-1
Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25), Blood, vol.93, pp.1355-1363, 1999. ,
Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity, Am J Surg Pathol, vol.34, pp.599-608, 2010. ,
Most non-parotid " acinic cell carcinomas " represent mammary analog secretory carcinomas ,
DOI : 10.1097/pas.0b013e3182841554
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686973
GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms, Head and Neck Pathology, vol.20, issue.4, pp.311-315, 2013. ,
DOI : 10.1007/s12105-013-0442-3
ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway, Cancer Research, vol.71, issue.3, pp.1060-1070, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-3096
Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry, Human Pathology, vol.34, issue.12, pp.1299-1304, 2003. ,
DOI : 10.1016/S0046-8177(03)00423-4
Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication, Journal of Clinical Pathology, vol.62, issue.7, pp.604-612, 2009. ,
DOI : 10.1136/jcp.2008.059675
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer, Journal of Clinical Oncology, vol.28, issue.16, pp.2784-2795, 2010. ,
DOI : 10.1200/JCO.2009.25.6529
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, Journal of Clinical Oncology, vol.31, issue.31, pp.3997-4013, 2013. ,
DOI : 10.1200/JCO.2013.50.9984
Mitotic Checkpoints and Chromosome Instability Are Strong Predictors of Clinical Outcome in Gastrointestinal Stromal Tumors, Clinical Cancer Research, vol.18, issue.3, pp.826-838, 2012. ,
DOI : 10.1158/1078-0432.CCR-11-1610
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups, Nature, vol.452, pp.346-352, 2013. ,
DOI : 10.1038/nature10983
ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma, Cancer Res, vol.58, pp.5046-5048, 1998. ,
Mammary analogue secretory carcinoma of salivary glands with high-grade transformation: report of 3 cases with the ETV6-NTRK3 gene fusion and analysis of TP53, b-catenin, EGFR, and CCND1 genes, Am J Surg Pathol, vol.38, pp.23-33, 2014. ,
Secretory carcinoma of the breast: Results from the survival, epidemiology and end results database, The Breast, vol.21, issue.3, pp.350-353, 2012. ,
DOI : 10.1016/j.breast.2012.02.013
ETV6 Disruption Does Not Predict Indolent Clinical Behavior in Secretory Breast Carcinoma, The Breast Journal, vol.18, issue.6, pp.604-606, 2012. ,
DOI : 10.1111/tbj.12041
Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature, World Journal of Surgical Oncology, vol.3, issue.1, p.35, 2005. ,
DOI : 10.1186/1477-7819-3-35
Carcinome s??cr??toire du sein chez l???homme, Annales de Pathologie, vol.24, issue.5, pp.432-435, 2004. ,
DOI : 10.1016/S0242-6498(04)93999-5